These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 12649400)

  • 1. The association of antinuclear antibodies with organ involvement and survival in systemic sclerosis.
    Hesselstrand R; Scheja A; Shen GQ; Wiik A; Akesson A
    Rheumatology (Oxford); 2003 Apr; 42(4):534-40. PubMed ID: 12649400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and serological associations with anti-RNA polymerase antibodies in systemic sclerosis.
    Harvey GR; Butts S; Rands AL; Patel Y; McHugh NJ
    Clin Exp Immunol; 1999 Aug; 117(2):395-402. PubMed ID: 10444276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and laboratory features of African-Brazilian patients with systemic sclerosis.
    Mendes C; Viana VST; Pasoto SG; Leon EP; Bonfa E; Sampaio-Barros PD
    Clin Rheumatol; 2020 Jan; 39(1):9-17. PubMed ID: 31065858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression of nailfold microvascular damage and antinuclear antibody pattern in systemic sclerosis.
    Sulli A; Ruaro B; Smith V; Pizzorni C; Zampogna G; Gallo M; Cutolo M
    J Rheumatol; 2013 May; 40(5):634-9. PubMed ID: 23457379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-centromere antibodies in a large cohort of systemic sclerosis patients: comparison between immunofluorescence, CENP-A and CENP-B ELISA.
    Mahler M; You D; Baron M; Taillefer SS; Hudson M; ; Fritzler MJ
    Clin Chim Acta; 2011 Oct; 412(21-22):1937-43. PubMed ID: 21756890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis.
    Kuwana M; Kaburaki J; Okano Y; Tojo T; Homma M
    Arthritis Rheum; 1994 Jan; 37(1):75-83. PubMed ID: 8129766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
    Hamaguchi Y
    J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis.
    Jacobsen S; Ullman S; Shen GQ; Wiik A; Halberg P
    J Rheumatol; 2001 Nov; 28(11):2454-9. PubMed ID: 11708418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features of Japanese systemic sclerosis (SSc) patients negative for SSc-related autoantibodies: A single-center retrospective study.
    Miyake M; Matsushita T; Takehara K; Hamaguchi Y
    Int J Rheum Dis; 2020 Aug; 23(9):1219-1225. PubMed ID: 32662135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-RNA polymerases and other autoantibody specificities in systemic sclerosis.
    Bunn CC; Denton CP; Shi-Wen X; Knight C; Black CM
    Br J Rheumatol; 1998 Jan; 37(1):15-20. PubMed ID: 9487245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic sclerosis: demographic, clinical and serological features in 100 Iranian patients.
    Poormoghim H; Moghadam AS; Moradi-Lakeh M; Jafarzadeh M; Asadifar B; Ghelman M; Andalib E
    Rheumatol Int; 2013 Aug; 33(8):1943-50. PubMed ID: 23344826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to RNA polymerase III in systemic sclerosis detected by ELISA.
    Santiago M; Baron M; Hudson M; Burlingame RW; Fritzler MJ
    J Rheumatol; 2007 Jul; 34(7):1528-34. PubMed ID: 17610318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease subsets, antinuclear antibody profile, and clinical features in 127 French and 247 US adult patients with systemic sclerosis.
    Meyer OC; Fertig N; Lucas M; Somogyi N; Medsger TA
    J Rheumatol; 2007 Jan; 34(1):104-9. PubMed ID: 17117486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antinuclear antibody pattern and autoantibody profiling of systemic sclerosis patients in a tertiary referral center in North India.
    Machhua S; Sharma SK; Kumar Y; Anand S; Handa S; Minz RW
    Pathol Int; 2022 May; 72(5):283-292. PubMed ID: 35319814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical relevance of serum antinuclear antibodies in Japanese patients with systemic sclerosis.
    Hamaguchi Y; Hasegawa M; Fujimoto M; Matsushita T; Komura K; Kaji K; Kondo M; Nishijima C; Hayakawa I; Ogawa F; Kuwana M; Takehara K; Sato S
    Br J Dermatol; 2008 Mar; 158(3):487-95. PubMed ID: 18205876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Low prevalence of anti-centromere antibodies in scleroderma in Morocco (about 272 cases)].
    Admou B; Arji N; Seghrouchni F; Missoum H; El Fenniri L; Amghar S; El Aouad R
    Ann Biol Clin (Paris); 2007; 65(3):291-7. PubMed ID: 17502303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a novel particle-based multi-analyte technology for the detection of anti-fibrillarin antibodies.
    Mahler M; Kim G; Roup F; Bentow C; Fabien N; Goncalves D; Palterer B; Fritzler MJ; Villalta D
    Immunol Res; 2021 Jun; 69(3):239-248. PubMed ID: 33913080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of indirect immunofluorescence and multiplex antinuclear antibody screening in systemic sclerosis.
    Shanmugam VK; Swistowski DR; Saddic N; Wang H; Steen VD
    Clin Rheumatol; 2011 Oct; 30(10):1363-8. PubMed ID: 21614475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific anti-nuclear antibodies in systemic sclerosis patients with and without skin involvement: an extended methodological approach.
    Van Praet JT; Van Steendam K; Smith V; De Bruyne G; Mimori T; Bonroy C; Elewaut D; Deforce D; De Keyser F
    Rheumatology (Oxford); 2011 Jul; 50(7):1302-9. PubMed ID: 21330340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognising the spectrum of scleromyositis: HEp-2 ANA patterns allow identification of a novel clinical subset with anti-SMN autoantibodies.
    Landon-Cardinal O; Baril-Dionne A; Hoa S; Meyer A; Leclair V; Bourré-Tessier J; Mansour AM; Zarka F; Makhzoum JP; Nehme J; Rich E; Goulet JR; Grodzicky T; Koenig M; Joyal F; Richard I; Hudson M; Targoff I; Satoh M; Fritzler MJ; Troyanov Y; Senécal JL
    RMD Open; 2020 Sep; 6(2):. PubMed ID: 32892170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.